Adult attachment and intimate relationship satisfaction among university students: the chain mediating roles of appreciation and sense of giving
Health-care AI is here. We don’t know if it actually helps patients.
I don’t need to tell you that AI is everywhere.
Or that it is being used, increasingly, in hospitals. Doctors are using AI to help them with notetaking. AI-based tools are trawling through patient records, flagging people who may require certain support or treatments. They are also used to interpret medical exam results and X-rays.
A growing number of studies suggest that many of these tools can deliver accurate results. But there’s a bigger question here: Does using them actually translate into better health outcomes for patients?
We don’t yet have a good answer.
That’s what Jenna Wiens, a computer scientist at the University of Michigan, and Anna Goldenberg of the University of Toronto, argue in a paper published in the journal Nature Medicine this week.
Wiens tells me she has spent years investigating how AI might benefit health care. For the first decade of her career she tried to pitch the technology to clinicians. Over the last few years, she says, it’s as though “a switch flipped.” Health-care providers not only appear much more interested in the promise of these technologies, they have also begun rapidly deploying them.
The problem is that many providers aren’t rigorously assessing how well they actually work.
Take “ambient AI” tools, for example. Also known as AI scribes, they “listen” to conversations between doctors and patients, then transcribe and summarize them. Multiple tools are available, and they are already being widely adopted by health-care providers.
A few months ago, a staffer at a major New York medical center who develops AI tools for doctors told me that, anecdotally, medics are “overjoyed” by the technology—it allows them to focus all their attention on their patients during appointments, and it saves them from a lot of time-consuming paperwork. Early studies support these anecdotes and suggest that the tools can reduce clinician burnout.
That’s all well and good. But what about patient health outcomes? “[Researchers] have evaluated provider or clinician and patient satisfaction, but not really how these tools are affecting clinical decision-making,” says Wiens. “We just don’t know.”
The same holds true for other AI-based technologies used in health-care settings. Some are used to predict patients’ health trajectories, others to recommend treatments. They are designed to make health care more effective and efficient.
But even a tool that is “accurate” won’t necessarily improve health outcomes. AI might speed up the interpretation of a chest X-ray, for example. But how much will a doctor rely on its analysis? How will that tool affect the way a doctor interacts with patients or recommends treatment? And ultimately: What will this mean for those patients?
The answers to those questions might vary between hospitals or departments and could depend on clinical workflows, says Wiens. They might also differ between doctors at various stages of their careers.
Take the AI scribes, as another example. Some research on AI use in education suggests that such tools can impact the way people cognitively process information. Could they affect the way a doctor processes a patient’s information? Will the tools affect the way medical students think about patient data in a way that impacts care? These questions need to be explored, says Wiens. “We like things that save us time, but we have to think about the unintended consequences of this,” she says.
In a study published in January 2025, Paige Nong at the University of Minnesota and her colleagues found that around 65% of US hospitals used AI-assisted predictive tools. Only two-thirds of those hospitals evaluated their accuracy. Even fewer assessed them for bias.
The number of hospitals using these tools has probably increased since then, says Wiens. Those hospitals, or entities other than the companies developing the tools, need to evaluate how much they help in specific settings. There’s a possibility that they could leave patients worse off, although it’s more likely that AI tools just aren’t as beneficial as health-care providers might assume they are, says Wiens.
“I do believe in the potential of AI to really improve clinical care,” says Wiens, who stresses that she doesn’t want to stop the adoption of AI tools in health care. She just wants more information about how they are affecting people. “I have to believe that in the future it’s not all AI or no AI,” she says. “It’s somewhere in between.”
This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and read articles like this first, sign up here.
Psychedelics get a boost from the White House
President Trump recently signed an executive order which aims to increase access to psychedelic drug treatments. He was joined at the signing by podcaster Joe Rogan, who said he’ ha’d messaged the president about research on the psychedelic ibogaine.
In this week’s STATus Report, host Alex Hogan chats with STAT Washington correspondent Daniel Payne about what the executive order does and doesn’t do. Hogan also looks at why ibogaine, and psychedelic drugs more broadly, are increasingly being taken seriously for stubbornly hard-to-treat conditions like addiction, depression, and PTSD.
Growing use of guest editors has turned some journals into a ‘playground of bad science’
Should academic journals begin to second guess guest editors?
That question gained new urgency last week when the British Medical Journal’s publishing group retracted nearly its entire guest-edited special edition of the Journal of Medical Genetics, dedicated to cancer immunotherapies. In the retraction note, the journal writes that it was, in part, because of “compromised peer review in almost all articles.” The notice garnered attention for its scope, but also because it exemplified larger concerns that research integrity advocates have with guest-edited editions, which are also called special issues in some journals.
Ensemble-based working memory updating and its computational rules.
Psychological Review, Vol 133(3), Apr 2026, 515-533; doi:10.1037/rev0000569
Manipulation plays a critical role in working memory, wherein understanding how items are represented during manipulation is a fundamental question. Previous studies on manipulation have primarily assumed independent representations by default (independent hypothesis). Here, we propose the ensemble hypothesis to challenge this conventional notion, suggesting that items are represented as ensembles undergoing updating during manipulation. To test these hypotheses, we focused on working memory updating in accordance with new information by conducting three delayed-estimation tasks under addition, removal, and replacement scenarios (Study 1). A critical manipulation involved systematically manipulating the mean orientation of all memory stimuli, either increasing (clockwise) or decreasing (counterclockwise) after the updating process. Following the independent hypothesis, memory errors would be similar under both conditions. Conversely, considering the biasing effect of the ensemble on individual representations, the ensemble hypothesis predicts that memories of individual items would be updated, aligning with the ensemble’s change direction. Namely, memory errors would be more positive in the increase-mean condition compared to the decrease-mean condition. Our results supported the ensemble hypothesis. Furthermore, to investigate the mechanisms underlying ensemble computations in updating scenarios, we conducted three ensemble tasks (Study 2) with similar designs to Study 1 and developed a computational model to quantify the contributions of each memory item. The results consistently demonstrated that addition involved complete updating, while removal led to incomplete updating. Across these three research parts, we propose that items are represented as dynamic ensembles during working memory updating processes. Furthermore, we elucidate the computational principles underlying ensembles throughout this process. (PsycInfo Database Record (c) 2026 APA, all rights reserved)
Adaptive computation as a new mechanism of dynamic human attention.
Psychological Review, Vol 133(3), Apr 2026, 534-559; doi:10.1037/rev0000572
A key role for attention is to continually focus visual processing to satisfy our goals. How does this work in computational terms? Here we introduce adaptive computation—a new computational mechanism of human attention that bridges the momentary application of perceptual computations with their impact on decision outcomes. Adaptive computation is a dynamic algorithm that rations perceptual computations across objects on-the-fly, enabled by a novel and general formulation of task relevance. We evaluate adaptive computation in a case study of multiple object tracking (MOT)—a paradigmatic example of selection as a dynamic process, where observers track a set of target objects moving amid visually identical distractors. Adaptive computation explains the attentional dynamics of object selection with unprecedented depth. It not only recapitulates several classic features of MOT (e.g., trial-level tracking accuracy and localization error of targets), but also captures properties that have not previously been measured or modeled—including both the subsecond patterns of attentional deployment between objects, and the resulting sense of subjective effort. Critically, this approach captures such data within a framework that is in-principle domain-general, and, unlike past models, without using any MOT-specific heuristic components. Beyond this case study, we also look to the future, discussing how adaptive computation may apply more generally, providing a new type of mechanistic model for the dynamic operation of many forms of visual attention. (PsycInfo Database Record (c) 2026 APA, all rights reserved)
Building a Science-Driven Business: How National Institutes of Health Funding Enabled an Evidence-Based Approach to Maternal Mental Health Innovation
The digital mental health (DMH) industry has grown drastically over the last decade; yet, many DMH products have failed to demonstrate meaningful clinical outcomes, in large part due to lack of scientific evidence. This viewpoint paper highlights an example of how early-stage DMH companies can prioritize science as a strategic advantage. We discuss Moment for Parents, an artificial intelligence–driven maternal mental health app built entirely with support from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program. We illustrate the advantages and challenges of building a science-backed product with federal funding. Benefits include credible evidence generation, independence in product development, and enhanced market differentiation. We also discuss the challenges of navigating the SBIR ecosystem, including grant writing and administrative demands, and aligning business objectives with federal research priorities. By showcasing both the promise and complexity of SBIR funding, this viewpoint paper offers actionable insights for founders and chief executive officers who aim to prioritize science in the DMH space.
<img src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/0353d3d1a7028c09b54629066fd3bca7" />
Understanding Collaborative CT and MRI Utilization Through Network Analysis: Retrospective Study Using Administrative Claims Data
Development of a Child Articulation Screening Test Within Digital Therapeutics: Delphi Study
Background: Speech sound disorders are common in children and are associated with an increased risk of academic reading difficulties. The COVID-19 pandemic further highlighted the need for remote and digitalized assessment tools. In South Korea, standardized instruments such as the Urimal Test of Articulation and Phonation and Assessment of Phonology and Articulation for children are widely used but have limitations, including reliance on face-to-face evaluation, and the absence of automated scoring. Objective: This study aimed to develop and establish the content validity of an articulation assessment tool that can overcome these limitations and be integrated into digital therapeutics (DTx). Methods: A 3-round modified Delphi survey was conducted between July and September 2025 with 92% (23/25) of the invited experts, including 52.2% (12/23) physiatrists and 47.8% (11/23) speech-language pathologists, with a mean professional experience of 10.69 (SD 5.09) years. All participants (23/23, 100%) completed all rounds. Panelists evaluated the appropriateness of word lists, phonological environments, and scoring criteria. Quantitative analyses, including calculations of content validity ratio (CVR), content validity index (CVI), and median and IQR, were performed. Consensus thresholds were set at a CVR of ≥0.39, a CVI of ≥0.78, a median of ≥3.5, and an IQR of ≤1.0. Items were retained only when all 4 criteria were satisfied. While formal qualitative analysis was not performed, the research team internally reviewed and synthesized core keywords and themes from the experts’ open-ended responses to guide the refinement of items. Results: These findings were summarized into four key areas: (1) modernization of word stimuli, (2) expansion of phonological coverage, (3) refinement of scoring criteria to reduce ambiguity, and (4) enhancement of result interpretability through visualization. In round 2, a revised 35-word list was evaluated across 25 items, of which 20 (80%) met all consensus criteria. In total, 20% (5/25) of the items failed to meet at least one threshold, including phonological environment adequacy (CVR=0.48; CVI=0.74), scoring redundancy (CVR=0.13; CVI=0.57), usefulness of proportion of whole-word correctness or percentage of word proximity (CVR=0.39; CVI=0.70), contribution of mean phonological length (CVR=0.22; CVI=0.61), and usefulness of feature-based indexes (CVR=0.30; CVI=0.65; IQR 2). Items that reached consensus showed CVR values of 0.57 to 0.91, CVI values of 0.78 to 0.96, a median score of 4, and IQR values of 0 to 1. In round 3, all remaining items achieved consensus. Conclusions: This Delphi study developed a novel articulation assessment tool with robust content validity. This tool includes updated word stimuli, diverse analysis indexes, and visualization features, thereby enhancing its clinical utility and suitability for integration into artificial intelligence–based DTx. By standardizing and digitalizing articulation assessments, this tool has the potential to support personalized and accessible interventions for children with speech sound disorders.
<img src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/482dc072cc319e77bd695decadaff1d1" />

